ER is dead

http://blog.alphametry.com/2015/03/off-the-cliff/

"In June 2014, the UK Financial Conduct Authority dropped a bombshell on the asset management industry’s already crowded regulatory landscape. After several months of consultation with industry players, the regulator concluded that all investment research was to be priced and further advised that dealing commissions may no longer be used to pay for research.

Five months of intensive lobbying later, the European Securities & Markets Authority declared they were backing down (for now), advising that ‘substantive research’ may continue to be financed by execution, albeit under stricter conditions. Is this regulatory upheaval the end of the road for equity research, or a fresh start?"

If it went through, it would indeed be a bad day for sell side research

I guess it’s time to shift careers.

can someone elaborate on the implications of this?. does this affect the US ER industry?

Yawn, will never happen.

(sigh) The Gods must hate my career ambitions (double sigh)